Exam 2 Flashcards

1
Q

Absorption

A

movement of drugs into the bloodstream from the site of delivery
-stomach
-skin
-vein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Factors accepting absorption

A

Drug transport
Physicochemical properties
Routes of Administration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

When pH is lower than pKa which form will predominate

A

protonated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

pKA - pH
4.2 - 7.4 = (-) what occurs
weak acid

A

unprotonated form predominates, drug can not cross barrier because it has a negative charge

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

pKa - pH
9.4 - 1.4 = (+) what occurs
weak base

A

protonated form predominates
can’t cross barrier, charge

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Fractional extent to which a dosage of drug reaches the systemic circulation is dependent on what 3 factors

A

Route of administration
Absorption
Metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Area under the curve (AUC) indicates what

A

overall amount of drug in blood after a given dose (over time)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Three factors that impact drug distribution

A

Protein binding
Tissue binding
Transporters

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

oral administration: absorption and limitations

A

absorption: variable, must cross intestinal mucosa
limitations: subject to metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How is uptake governed by pH in oral absorption

A

-weak acids absorbed from stomach and upper intestine
-weak bases absorbed better from upper intestine rather than from stomach

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Oral absorption factors

A

-accelerating gastric emptying will increase rate of absorption
-delaying gastric emptying will decrease rate of absorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Controlled release preparations in oral absorption

A

-designed for slow, uniform absorption of drug
-reduce frequency of administration
-more uniform blood levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Limitations of controlled release preparations

A

dose dumping increases toxicity
increase stomach acidity with high-fat meal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

sublingual administration

A

-venous drainage through superior vena cava
-useful with more lipid soluble drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

transdermal absorption

A

intact skin provides a lipid barrier for transdermal absorption
oily vehicles (improves permeability)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Rectal administration

A

absorption may be incomplete
used when patient is vomiting or unconscious

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Parenteral administration

A

-injections allow for absorption by simple diffusion from frug depot into bloodstream
-avoid first-pass metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

IV injection

A

-useful for poor soluble suspensions and depot formulations
-not good for large volumes
-potential pain at injection site

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

IM injection

A

-self-administration
-precluded during anticoagulant therapy
-many variabilities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Intraarterial injection

A

-circumvented to deliver drug directly to tissue or organ
-used for diagnostic agents and chemo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Intrathecal injection

A

injection into space surrounding spinal cord, useful for drugs that cannot cross the blood brain barrier or limiting effect to spinal cord or meninges

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

pulmonary absorption

A

absorption through pulmonary epithelium and mucous membranes of the respiratory tract, avoids first pass hepatic metabolism, directs application of drug to target tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Pharmaceutical equivalence

A

same active form, concentration, dosage form, and route of administration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Bioequivalence

A

indicated when rates of extent of bioavailability of active pharmaceutical ingredient (API) do not differ significantly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
What is drug distribution dependent on
cardiac output, blood flow, capillary permeability, tissue volume
25
Redistribution of drugs
Rapid distribution to muscle and liver Slower distribution to adipose tissue
26
What carriers help drugs bind to plasma protein
albumin for acidic drugs a1-acid glycoprotein for basic drugs
27
Tissue binding
-Accumulate by active transport -Lipid soluble drugs stored in body fat
28
What drugs bind to bone tissue
Tetracycline and aminoglycoside antibiotics
29
Blood brain barrier
-composed of capillary endothelial cells -regulates distribution of chemicals to the brain membrane transporters (efflux and influx)
30
What glial cells are located where
BBB (includes astrocytes and microglia)
31
what cells separate cerebrospinal fluid from blood
epithelial cells
32
Phase 1 functionalization reactions
Introduce or expose functional groups Result in both active and inactive compounds Net result is water-soluble compounds that can be excreted into urine
33
Phase 2 biosynthetic (conjugation) reactions
-covalent linkage between functional group on drug -polar conjugates usually inactive and excreted rapidly
34
What is first order kinetics?
-constant fraction of drug is eliminated per unit time -drug metabolism proportional to plasma concentration
35
What is zero order kinetics?
-limited metabolic capacity -constant amount of drug metabolized per unit of time
36
some drugs alter metabolism of other drugs through
-induction of enzymes (increased expression of drug metabolizing enzymes) -inhibition of enzymes (blockade of drug metabolizing enzymes)
37
Glomerular filtration
only unbound drug filtered into tubular lumen from the blood
38
Active proximal tubular secretion
-ATP-binding cassette transporters secrete anions and metabolizes into tubular fluid -Other ABC transporters are more selective for organic cations or neutral substrates
39
Active distal tubular reabsorption
-From tubular lumen to systemic circulation by membrane transporters -most reabsorption is by nonionic diffusion
40
Renal excretion
concomitant reabsorption of non-ionized weak acids and weak bases, depends on pH
41
Biliary excretion
potential recycling through reabsorption from GI tract to systemic circulation
42
What is F (bioavailability)
fraction of a drug absorbed into the systemic circulation -depends on route of administration, absorption, metabolism, excretion
43
What is V (volume of distribution)
apparent space of body available to contain a drug based on amount given and concentration in systemic circulation -impact by plasma binding protein, age, gender, body composition
44
What is CL (clearance)
measures body efficiency in drug elimination -use in designing dosing regimens -can follow either first order or zero order
45
Steady State Concentration (Css)
Concentration achieved when intake of drug is in dynamic equilibrium with elimination of drug
46
Km and vm
Km is the concentration at which half max rate of elimination is reached vm is the max rate of elimination
47
Clinical pharmacokinetics parameters can be utilized to design dosing regimens
maintain plasma concentrations within therapy window maintenance doses can be adjusted loading doses used to achieve rapid onset
48
Maintenance Dose
Series of repetitive doses or continuous infusion to maintain steady state
49
What can polymorphisms impact
Protein structure Function Pattern of expression in
50
SNPs
May change coding for proteins or impact expression
51
Insertions or deletions (indels)
Like SNPs (change coding)
52
Copy number variations
Gene duplications or deletions
53
Non-synonymous (missense)
Change impacts protein sequence Amina acid substitution or stop translation
54
Synonymous (sense)
Change does not impact protein structure May impact expression
55
Non-coding SNPs
3’ or 5’ untranslated regions (promoter or enhancer regions) Intronic/intergenic regions
56
UGT1A1
TA repeats (insertions) in promoter impact expression of enzyme -range is from 4 to 9 repeats -6 or 7 repeats most common
57
CYP2D6
Ultra rapid metabolized phenotype implicated in variable responses to antidepressants therapy
58
CYP2D6
20-25% of drugs are metabolized by the enzyme Can have poor or ultra-rapid metabolism
59
What does poor drug metabolism do in your body
Can’t eliminate drugs so they stay in the system and produce toxic effects
60
CYP3A5 expressed in higher percentage of individuals of ________ descent than in caucasians
african
61
SNP in intron __ encode stop codon, resulting in truncated protein
3
62
What are the two main classes of transporters and what do they do
SLC-include both active and non-active transporters ABC-active transporters needing ATP
63
What are the three adverse effects of membrane transporters
decreased uptake in clearance drugs enhanced uptake or reduced efflux from target organs decreased efflux of endogenous compounds
64
Passive diffusion
electrochemical potential gradient
65
Facilitated diffusion
Membrane SLC transporters facilitate diffusion
66
Primary active transport
ABC transporters hydrolyze ATP through intrinsic ATPase activity
67
Secondary active transport
SLC transporters move one solute against ECG by transporting another solute with ECG
68
Vectorial transport
The net flow of drugs from one compartment to another depending opinion the relative orientation and function of multiple transporters
69
ADME transport of vectorial transport
Absorption - absorb in small intestine Distribution - CNS penetration at the BBB Metabolism - Hepatobiliary transport in the liver Elimination - tubular secretion in the kidney
70
Role for type 2 nuclear receptors
Ligand binding and formation of heterodimers Binding to specific elements in enhancer regions of target genes Changes in transcription or transporters and other proteins
71
Altered transporter function has been linked to human disease what receptor is tangier disease
ABCA
72
Altered transporter function has been linked to human disease what receptor malfunction results in amyotrophic lateral sclerosis
High affinity glutamine and neutral amino acid transporter
73
7 ABC transporters are identified. Which two play important roles in drug transport
ABCB1 ABCC ABCG
74
Induction of ________ can decrease systemic exposure to substrates such as digoxin
ABCB1
75
Inhibition can reduced _________ of digoxin
Excretion
76
Role: OATP, OAT OCT
OATP, OAT- transport anions OCT- transports cations
77
Role of NTCP
Transports bile salts
78
Phase 1 bio transformation reactions
Increase water solubility by exposing functional groups CYP 450 enzymes Epoxied hydrolases Flavin containing monooxygenases
79
Phase 2 conjugating enzymes
Increase hydrophilicity and molecular weight Inactive compounds Transferases (UPD, sulfur, glutathione, acetyl, methyl)
80
CYP 3A 4/5 involved with metabolism of _____% of all drugs
50
81
UDP UGT1A1 is important for metabolizing drugs and bilirubin what disease can it cause and what is it effects
Gilbert’s syndrome Toxic for patients with low binding levels
82
Induction of drug metabolizing enzymes increase metabolism thereby ________ drug exposure and _________ clearance
Decreasing Enhancing